Showing 3711-3720 of 5956 results for "".
- CooperVision Launches MiSight 1 Day Switch Guarantee to Support Myopia Management Adoptionhttps://modernod.com/news/coopervision-launches-misight-1-day-switch-guarantee-to-support-myopia-management-adoption/2487033/CooperVision has introduced the MiSight 1 day Switch Guarantee, a new program aimed at helping eye care professionals transition children from traditional single vision contact lenses into myopia management treatment with MiSight 1 day lenses.
- Early Screening and Outdoor Activity Key to Tackling Childhood Myopia, Italian Study Findshttps://modernod.com/news/early-screening-and-outdoor-activity-key-to-tackling-childhood-myopia-italian-study-finds/2486939/Key Takeaways Early and regular eye screenings—starting around age 3—are critical for detecting and managing childhood myopia before it progresses
- International Congress of Scleral Contacts: A Chance to Advance Your Skillshttps://modernod.com/news/international-congress-of-scleral-contacts-a-chance-to-advance-your-skills/2486922/Given that scleral contact lenses can manage corneal conditions, such as keratoconus, and treat dry eye disease effectively, it makes sense for ODs to be aware of the latest related innovations to continue to meet these patients’ vision and comfort needs. This is where the International Congress
- Theialife Appoints Thomas Ruggia as President and CEOhttps://modernod.com/news/theialife-appoints-thomas-ruggia-as-president-and-ceo/2486807/Theialife announced the appointment of Thomas Ruggia as President and Chief Executive Officer. Mr. Ruggia will oversee the company’s development, operational, and corporate strategy as it approaches key milestones, including the planned initiation of phase 3 clinic
- Focus A-Eye to Launch Inaugural AI Summit Advancing the Future of Ophthalmologyhttps://modernod.com/news/focus-a-eye-to-launch-inaugural-ai-summit-advancing-the-future-of-ophthalmology/2486795/Focus A-Eye, a specialized medical education and innovation forum dedicated to advancing the application of AI in ophthalmology, has announced the launch of its inaugural Focus A-Eye Summit, set to take place on Saturday, May 2, 2026, in Denver, Colorado.
- National Eye Institute Seeks Public Input for 2026–2031 Strategic Planhttps://modernod.com/news/national-eye-institute-seeks-public-input-for-20262031-strategic-plan/2486520/The National Eye Institute (NEI) has issued a Request for Information (RFI) as it begins developing its strategic plan for 2026 through 2031, inviting fe
- Zeiss Expands Ophthalmic Workflow Portfolio in Canada with Diagnostic, Visualization, and Therapeutic Solutionshttps://modernod.com/news/zeiss-expands-ophthalmic-workflow-portfolio-in-canada-with-diagnostic-visualization-and-therapeutic-solutions/2486373/Key Takeaways Zeiss introduced a broader portfolio of diagnostic devices, therapeutic lasers, and digital workflow tools to enhance eye care deliv
- WCO, Alcon Launch Dry Eye Management Map for Optometrists Worldwidehttps://modernod.com/news/wco-alcon-launch-dry-eye-management-map-for-optometrists-worldwide/2486349/The World Council of Optometry (WCO) and Alcon have launched the Dry Eye Management Map, a new online interactive tool designed to help optometrists evaluate and manage dry eye disease in cl
- Vital Tears and Brightstar Therapeutics Form Joint Medical Advisory Boardhttps://modernod.com/news/vital-tears-and-brightstar-therapeutics-form-joint-medical-advisory-board/2486040/Vital Tears and Brightstar Therapeutics have announced the formation of a joint Medical Advisory Board, bringing together nine leaders in ophthalmology and optometry to help guide the organizations’ expanding clinical and scientific initiatives.
- Edinburgh Biosciences Showcases Light-Based Cataract Treatment Platform at 100% Optical 2026https://modernod.com/news/edinburgh-biosciences-showcases-light-based-cataract-treatment-platform-at-100-optical-2026/2486017/At the 100% Optical 2026 meeting, Edinburgh Biosciences introduced the SDS-100, the company’s proprietary system designed to deliver its Photon Protein Modulation (PPM) treatment. The exhibition provided the first opportunity f